Elanco Animal Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	4,591	4,439	4,417	4,411	4,764	3,271
Revenue Growth (YoY)	3.08%	0.50%	0.14%	-7.41%	45.64%	6.51%
Cost of Revenue	2,068	2,003	1,931	1,913	2,068	1,577
Gross Profit	2,523	2,436	2,486	2,498	2,696	1,694
Selling, General & Admin	1,386	1,308	1,280	1,259	1,395	988
Research & Development	356	344	327	321	369	329
Amortization of Goodwill & Intangibles	534	527	548	528	556	360
Operating Expenses	2,276	2,179	2,155	2,108	2,320	1,677
Operating Income	247	257	331	390	376	17
Interest Expense	-186	-235	-277	-241	-236	-150
Currency Exchange Gain (Loss)	-35	-12	-40	-28	-35	-4
Other Non Operating Income (Expenses)	-	-12	-12.5	-10	22	-60
EBT Excluding Unusual Items	26	-2	1.5	111	127	-197
Merger & Restructuring Charges	-3	-62	-93	-98	-336	-702
Impairment of Goodwill	-	-	-1,042	-	-	-
Gain (Loss) on Sale of Investments	-	-	-	-	-	11
Gain (Loss) on Sale of Assets	-	640	-	-	-	211
Asset Writedown	-29	-81	-32	-81	-	-
Legal Settlements	-	-	-27.5	-	-10	-
Other Unusual Items	-10	-7	-2	-4	-352	-
Pretax Income	-16	488	-1,195	-72	-571	-677
Income Tax Expense	-52	150	36	6	-88	-103
Net Income	36	338	-1,231	-78	-483	-574
Net Income to Common	36	338	-1,231	-78	-483	-574
Net Income Growth	-82.44%	-	-	-	-	-
Shares Outstanding (Basic)	496	494	492	488	487	441
Shares Outstanding (Diluted)	501	497	492	488	487	441
Shares Change (YoY)	0.93%	1.02%	0.82%	0.23%	10.38%	19.20%
EPS (Basic)	0.07	0.68	-2.50	-0.16	-0.99	-1.30
EPS (Diluted)	0.07	0.68	-2.50	-0.16	-0.99	-1.30
EPS Growth	-82.84%	-	-	-	-	-
Free Cash Flow	368	394	131	281	324	-176
Free Cash Flow Per Share	0.73	0.79	0.27	0.57	0.67	-0.40
Gross Margin	54.95%	54.88%	56.28%	56.63%	56.59%	51.79%
Operating Margin	5.38%	5.79%	7.49%	8.84%	7.89%	0.52%
Profit Margin	0.78%	7.61%	-27.87%	-1.77%	-10.14%	-17.55%
Free Cash Flow Margin	8.02%	8.88%	2.97%	6.37%	6.80%	-5.38%
EBITDA	882	879	971	1,007	1,040	499
EBITDA Margin	19.21%	19.80%	21.98%	22.83%	21.83%	15.25%
D&A For EBITDA	635	622	640	617	664	482
EBIT	247	257	331	390	376	17
EBIT Margin	5.38%	5.79%	7.49%	8.84%	7.89%	0.52%
Effective Tax Rate	-	30.74%	-	-	-	-
Advertising Expenses	-	236	207	201	248	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.